FDA Approves First Drug for Treatment of Resistant CMV FDA Approves First Drug for Treatment of Resistant CMV

Transplant patients are particularly vulnerable to cytomegalovirus (CMV) infection, which can lead to organ loss or death.FDA Approvals
Source: Medscape Infectious Diseases Headlines - Category: Infectious Diseases Tags: Transplantation News Alert Source Type: news